ASM
TVGN icon

ATW SPAC Management’s Tevogen Bio Holdings TVGN Stock Holding History

ATW SPAC Management’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,000
Closed -$507K – 216
2022
Q3 		$507K Hold
1,000
– – 0.08% 146
2022
Q2 		$501K Hold
1,000
– – 0.07% 160
2022
Q1 		$500 Buy
+1,000
New +$497K 0.07% 162

Other funds holding TVGN

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

ATW SPAC Management's TVGN Position: Q4 2022 in Review

ATW SPAC Management sold out of Tevogen Bio Holdings (TVGN) in Q4 2022, closing a stake of 1,000 shares — an estimated $507K sold.

ATW SPAC Management first reported a position in TVGN in Q1 2022 and held it in 3 quarters. The position peaked at $507K in Q3 2022. 64 funds tracked by Wall St. Rank hold TVGN as of Q4 2022.

  • ATW SPAC Management reported no remaining Tevogen Bio Holdings position as of Q4 2022 after selling out during the quarter.
  • ATW SPAC Management sold 1,000 Tevogen Bio Holdings shares in Q4 2022, an estimated $507K.
  • ATW SPAC Management first reported a position in Tevogen Bio Holdings in Q1 2022 and held it in 3 quarters.
  • ATW SPAC Management's Tevogen Bio Holdings position peaked at $507K in Q3 2022.
  • 64 funds tracked by Wall St. Rank held Tevogen Bio Holdings as of Q4 2022.

Based on ATW SPAC Management's 13F filing for Q4 2022, filed 14 Feb 2023.